Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (79)
  • 2024 (109)
  • 2023 (101)
  • 2022 (60)
  • 2021 (32)
  • 2020 (8)
  • 2019 (2)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (230)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (242)
  • Fentanyl Awareness (152)

Drug Name

  • Fentanyl (106)
  • Opioids (47)
  • Oxycodone (37)
  • Methamphetamine (18)
  • Synthetic Opioids (15)
  • Hydromorphone (13)
  • Cocaine (8)
  • Benzodiazepines (7)
  • Heroin (7)
  • Morphine (6)
  • Marijuana (Cannabis) (4)
  • Amphetamines (3)
  • Methadone (3)
  • Steroids (3)
  • Ketamine (1)
  • Marijuana Concentrates (1)
  • Xylazine (1)

Field Division

  • Washington, DC (41)
  • Houston (40)
  • New England (35)
  • New York (29)
  • Seattle (28)
  • Omaha (23)
  • Atlanta (19)
  • Chicago (19)
  • New Jersey (17)
  • Rocky Mountain (17)
  • Sede (16)
  • Miami (15)
  • Louisville (14)
  • New Orleans (14)
  • St. Louis (14)
  • Los Angeles (13)
  • El Paso (10)
  • Phoenix (8)
  • San Francisco (8)
  • Dallas (5)
  • San Diego (4)
  • Detroit (1)
Clear All Results
PRESS RELEASE

New Haven Pharmacy and Owner Agree to Pay $120,000 to Settle Controlled Substances Act Allegations

Abril 23, 2024
NEW HAVEN, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, and Stephen Belleau, Acting Special Agent in Charge of the Drug Enforcement Administration for New England, today announced that Cornerstone Pharmacy, Inc. (doing business as “Whalley Drug”), and its owner, YONG KWON, have entered into...
Abril 23, 2024
PRESS RELEASE

Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations

Abril 10, 2024
NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...
Abril 10, 2024
PRESS RELEASE

Domestic Trafficker Admits to Possession with Intent to Distribute Over 2,000 Counterfeit Pills

Abril 04, 2024
LAREDO, Texas – A 40-year-old resident of Lake Charles, Louisiana, has pleaded guilty to conspiring to possess with intent to distribute more than 40 grams of fentanyl, announced Drug Enforcement Administration Special Agent in Charge Daniel C. Comeaux, Houston Division and U.S. Attorney Alamdar S. Hamdani. Walter Wellington Somers admitted...
Abril 04, 2024
PRESS RELEASE

Idaho Doctor Pays $96,000 to Settle Allegations That He Wrote Unlawful Prescriptions

Abril 03, 2024
POCATELLO – Dr. Gerald Knouf, a family medicine doctor formerly of Pocatello, Idaho, agreed to pay $96,000 to resolve allegations that he wrote unlawful prescriptions, prescribed dangerous combinations of drugs, and billed Medicare and Medicaid for services that were not performed, U.S. Attorney Josh Hurwit announced today. The settlement also...
Abril 03, 2024
PRESS RELEASE

Owner Of New Jersey Company Admits to Evading U.S. Customs Duties and His Company Agrees to a $3.1 Million Settlement Agreement

Marzo 29, 2024
NEWARK, N.J. – The owner of a New Jersey company today admitted mislabeling hazardous chemicals entering the United States and evading customs duties, DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today. George Volpe, 60, of Roseland, New Jersey, owner...
Marzo 29, 2024
PRESS RELEASE

Chemical Importer to Pay $300,000 in Civil Penalties for Alleged Violations of the Controlled Substances Act

Marzo 25, 2024
WACO, Texas – Shrieve Chemical Company, LLC, a Drug Enforcement Administration-registered importer and distributor of listed chemicals, has agreed to pay $300,000 in civil penalties to resolve allegations that it violated provisions of the Controlled Substances Act, 21 U.S.C. §§ 801 et seq. In December 2022, DEA diversion investigators conducted...
Marzo 25, 2024
PRESS RELEASE

Connecticut U.S. Attorney’s Office and DEA New England Release PSA Warning of Fentanyl and Counterfeit Pills

Marzo 19, 2024
NEW HAVEN, Conn. – The U.S. Attorney’s Office for the District of Connecticut and the New England Field Division of the Drug Enforcement Administration have released a public service announcement asking Connecticut residents to remain vigilant during this ongoing opioid abuse epidemic, and issuing a warning about the increasing percentage...
Marzo 19, 2024
PRESS RELEASE

Nurse Practitioner Sentenced to 70 Months for Unlawful Drug Distribution

Marzo 01, 2024
ALBANY, NEW YORK – Danielle Simonson, age 52, of Fort Ann, New York, was sentenced today to 70 months in prison for distributing controlled substances outside the course of professional practice and for no legitimate medical purpose. United States Attorney Carla B. Freedman; Special Agent in Charge Frank A. Tarentino...
Marzo 01, 2024
PRESS RELEASE

Two Charged in Connection with Search of Bronx Drug Mail Distribution Center Containing Approximately 100,000 Pills Suspected of Fentanyl and Meth

Febrero 27, 2024
NEW YORK CITY - Damian Williams, the United States Attorney for the Southern District of New York; Frank A. Tarentino III, the Special Agent in Charge of the New York Division of the Drug Enforcement Administration; and Erin Keegan, the Acting Special Agent in Charge of the New York Field...
Febrero 27, 2024
PRESS RELEASE

DEA Issues Letter to E-Commerce Companies on the Sale of Pill Presses Used to Make Fentanyl Pills

Febrero 26, 2024
WASHINGTON – The U.S. Drug Enforcement Administration today issued a letter to e-commerce companies regarding the sale of pill presses. As regulated entities under the Controlled Substances Act (CSA), e-commerce platforms are generally required to comply with CSA recordkeeping, identification, and reporting requirements on the distribution, importation, and exportation of...
Febrero 26, 2024
Showing 151 - 160 of 391 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 12
  • Página 13
  • Página 14
  • Página 15
  • Current page 16
  • Página 17
  • Página 18
  • Página 19
  • Página 20
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster